Ld Path Group: FIRST ROLLOUT OF AI-BASED CANCER DETECTION FOR NHS PATIENTS

LDPath will deploy Ibex's Galen Prostate, an AI-powered solution to support pathologists in enhancing diagnostic accuracy and efficiency In recent years, a global increase in cancer cases has coincided with a decline in the number of pathologists around the world. Traditional pathology involves manual processes that have remained unchanged for years, where slides are analysed by pathologists using microscopes, and reporting is often carried out on pieces of paper. Limited availability of pathologists requires couriers to transport glass slides containing tissue samples between different locations to access expert opinions. The shortage of pathologists in the UK has led to delaysThe post FIRST ROLLOUT OF AI-BASED CANCER DETECTION FOR NHS PATIENTS appeared first on FutureScot.